MGNX

Macrogenics Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 2/10
  • Value↓ 1/10
Macrogenics sales and earnings growth
MGNX Growth
Fair
  • Revenue Y/Y↓ 1.22%
  • EPS Y/Y↓ -23.60%
  • FCF Y/Y↓ 0.77%
Macrogenics gross and profit margin trends
MGNX Profitability
Fair
  • Gross margin ↑ 74.40%
  • EPS margin↓ -44.80%
  • ROIC 5Y↓ -37.55%
Macrogenics net debt vs free cash flow
MGNX Risk
Poor
  • Debt / Equity↑ 5.0
  • Debt / FCF↓ 0.5
  • Interest coverage↓ -4.3

Macrogenics stock volatility is higher than the overall market. We give it a Poor risk rating.

↗ More Biotechnology stocks